Inventor · disambiguated record
Diane Stephenson
Also filed as: STEPHENSON DIANE T
2 granted patents·31 pending applications·73 citations·filing 1993–2006
66Inventor score
Top patents by PatentIndex Score
33 records- 0187US5478857AUse of PLA2 inhibitors as treatment for alzheimer's diseaseLILLY CO ELI·Filed 1993·Granted Dec 26, 1995·63 cites·12 claims
- 0253US2005080083A1Compositions of a cyclooxygenase-2 selective inhibitor and an angiotensin II receptor antagonist for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0353US2005101597A1Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0452US5563164APhospholipase A2 inhibitorsLILLY CO ELI·Filed 1995·Granted Oct 8, 1996·10 cites·11 claims
- 0552US2005159403A1Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0652US2004229803A1Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of pain, inflammation or inflammation mediated disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0752US2004224940A1Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0852US2004220187A1Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of pain, inflammation or inflammation mediated disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0952US2005159419A1Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1052US2006135506A1Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1152US2005054646A1Compositions of a cyclooxygenase-2 selective inhibitor and an antioxidant agent for the treatment of central nervous system disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1252US2006160776A1Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1352US2005070524A1Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1452US2005101629A1Compositions of a chromene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1552US2005009733A1Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1651US2004147581A1Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapyPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1751US2004171664A1Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive eventPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1849US2005070543A1Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ACE inhibitor for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1949US2005130971A1Compositions of a cyclooxygenase-2 selective inhibitor and phosphodiesterase inhibitor for the treatment of ischemic mediated central nervous system disorders or injuryPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2049US2005075341A1Compositions of a cyclooxygenase-2 selective inhibitor and an IKK inhibitor for the treatment of ischemic mediated central nervous system disorders or injuryPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2149US2005113376A1Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injuryPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2249US2005085478A1Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2349US2005080084A1Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2448US2004176378A1Compositions of a cyclooxygenase-2 selective inhibitor and an amphetamine for the treatment of reduced blood flow to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2547US2005113434A1Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injuryPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2645US2005148589A1Compositions of a cyclooxygenase-2 selective inhibitor and a neurotrophic factor-modulating agent for the treatment of central nervous system mediated disordersPHARMACIA & UPJOHN CO LLC·Filed 2004·Application pending·0 cites
- 2743US2007149591A1Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injurySTEPHENSON DIANE T·Filed 2006·Application pending·0 cites
- 2843US2005159471A1Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2943US2005113433A1Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3043US2005026919A1Compositions of a cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3140US2004122011A1Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapyPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3236US2004006100A1Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (COX 2) inhibitor(S)Filed 2003·Application pending·0 cites
- 3336US2004034083A1Combination therapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX2) inhibitor(s)Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Diane Stephenson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →